NASDAQ:IBB
iShares Nasdaq Biotechnology Index Fund ETF News
$132.96
+2.31 (+1.77%)
At Close: May 03, 2024
Where Are Biotech ETFs Headed After Q4 Earnings?
05:51pm, Wednesday, 14'th Feb 2024
Look into how Biotech ETFs performed after Q4 earnings.
Health care's underperformance last year sets it up well for 2024, says Mara Goldstein
07:34am, Thursday, 08'th Feb 2024
Mara Goldstein, Biotech Analyst at Mizuho, discusses health care's outperformance this week.
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now?
07:21am, Thursday, 01'st Feb 2024
Launched on 02/05/2001, the iShares Biotechnology ETF (IBB) is a smart beta exchange traded fund offering broad exposure to the Health Care ETFs category of the market.
Should You Invest in the iShares Biotechnology ETF (IBB)?
07:21am, Thursday, 25'th Jan 2024
Looking for broad exposure to the Healthcare - Biotech segment of the equity market? You should consider the iShares Biotechnology ETF (IBB), a passively managed exchange traded fund launched on 02/05
Healthcare In 2024: Navigating The Biopharma Bull Run
11:22pm, Wednesday, 17'th Jan 2024
The healthcare sector presents a unique investment opportunity in 2024 due to attractive valuation and uncorrelated/robust cashflow of healthcare. Biopharma companies have pricing power and ability to
An ETF Nerd's Exchange Conference Preview
11:28am, Tuesday, 16'th Jan 2024
The long-awaited spot bitcoin ETFs are trading after a decade of waiting. So now the ETF and advisor community has some available brain capacity to look forward.
Bullish Continuation in '24? 3 Market Areas to Watch
02:17pm, Wednesday, 10'th Jan 2024
Will stocks continue into 2024? Stock Strategist Andrew Rocco shares his prediction and unveils 3 important market areas to monitor.
Biotech ETFs Stage Solid Comeback at the Start of 2024
12:47pm, Tuesday, 09'th Jan 2024
The biotech space staged a strong comeback at the start of 2024, driven by multi-billion dollar deals, upbeat clinical results and cutting-edge medical advances like CRISPR gene-editing hitting prime-
Biotech ETF (IBB) Hits New 52-Week High
10:31am, Tuesday, 09'th Jan 2024
For investors seeking momentum, iShares Biotechnology ETF IBB is probably on the radar. The fund just hit a 52-week high and is up 25% from its 52-week low price of $11.83/share.
Equity CEFs/ETFs: Top Picks For 2024 - Part II
11:01am, Friday, 05'th Jan 2024
In Part I of my Top Picks For 2024, I explained why we saw such extreme valuation losses in most equity CEFs in 2023 and what that could-mean for 2024. In my opinion, liquidity was the over-riding fac
5 Top-Ranked ETF Winners of December With More Room for Gains
09:46am, Friday, 29'th Dec 2023
Wall Street witnessed an upbeat December due to moderation in inflationary pressures, the likelihood of Fed rate cuts in 2024 and decent corporate earnings.
Dr. Scott Gottlieb talks Big Pharma's buying spree
04:26pm, Wednesday, 27'th Dec 2023
Dr. Scott Gottlieb, joins 'Closing Bell' to discuss the government's regulation on the pharmaceutical industry.
Wedbush's Laura Chico talks biotech investing in 2024
05:21pm, Tuesday, 26'th Dec 2023
Laura Chico, Wedbush Biotech Analyst, joins 'Closing Bell Overtime' to talk investing in biotech.
Buy or bail on biotech: Here's what you need to know
01:40pm, Tuesday, 26'th Dec 2023
Biotech is up double digits this month. Piper Sandler says that the sector is breaking out.
What Are Key Stock Market ETFs Saying About Santa Rally Now?
05:12pm, Sunday, 17'th Dec 2023
This is a great time to examine the weekly charts of the Economic Modern Family. We like that timeframe for now with only a short number of trading days left.
